McKesson signs agreement to acquire minority stake in Option Care Health
CD&R and McKesson will buy Option Care Health for $5.8 billion, with CD&R holding majority ownership. The deal closes in early 2027.
See the latest news and media coverage for McKesson. We track all announcements, press releases, and industry mentions in real time, all in one place.
Healthcare distribution and services company
mckesson.comLast updated
In short: McKesson acquired Precision Medicine, invested in Option Care Health, raised guidance, and extended its CVS Health distribution agreement.
CD&R and McKesson will buy Option Care Health for $5.8 billion, with CD&R holding majority ownership. The deal closes in early 2027.
McKesson reaffirmed its fiscal year 2027 adjusted EPS guidance of $44.20 to $45.00 and long-term growth rate expectations during the announcement.
McKesson acquires the firm for $2.25 billion to enhance clinical research and biopharma commercialization services within its Oncology segment.
The board declared a regular dividend payable October 1, 2026, to shareholders of record on September 1, 2026.
McKesson (MCK) closed at $1,030.12 in the latest trading session, marking a +1.95% move from the prior day. The stock's change was more than the...
US drug distributor McKesson and private equity firm Clayton Dubilier & Rice are nearing a deal to...
Cardinal Health and McKesson are extending their existing distribution agreements with CVS Health, paving the way for the two companies to continue supplying drugs to...
Reuters reported that McKesson Corporation (NYSE:MCK) said it would buy privately held Precision Medicine Group in a deal valued at about $2.25 billion as part...
Track McKesson and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to McKesson and other trending companies.